NCT02814084View on ClinicalTrials.gov

Prevena Incision Management

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 13, 2016

Primary Completion Date

February 9, 2020

Study Completion Date

February 9, 2020

Conditions
Cardiac EventArrest; Cardiac, Complicating SurgeryCoronary Bypass Graft StenosisComplication of Coronary Artery Bypass Graft
Interventions
DEVICE

Bilateral Internal Mammary Artery grafts

Sternal Wound Edge Oxygenation in patients undergoing Coronary Artery bypass surgery with Bilateral Internal Mammary Artery grafts

DEVICE

Prevena

The Prevena wound management system applies negative pressure to the closed wound for up to 7 days and is associated with lower rates of surgical site infection.

Trial Locations (1)

S10 2JF

Sheffield Teaching Hospitals NHS FT, Sheffield

All Listed Sponsors
collaborator

3M

INDUSTRY

lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT02814084 - Prevena Incision Management | Biotech Hunter | Biotech Hunter